SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-034397
Filing Date
2020-03-17
Accepted
2020-03-17 08:30:18
Documents
23
Period of Report
2020-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012940d1_8k.htm 8-K 48699
2 EXHIBIT 2.1 tm2012940d1_ex2-1.htm EX-2.1 728986
3 EXHIBIT 99.1 tm2012940d1_ex99-1.htm EX-99.1 70150
4 EXHIBIT 99.2 tm2012940d1_ex99-2.htm EX-99.2 35308
5 EXHIBIT 99.3 tm2012940d1_ex99-3.htm EX-99.3 29200
6 GRAPHIC tm2012940d1_ex99-2img001.jpg GRAPHIC 3870
7 GRAPHIC tm2012940d1_ex99-3img01.jpg GRAPHIC 66648
8 GRAPHIC tm2012940d1_ex99-3img02.jpg GRAPHIC 186435
9 GRAPHIC tm2012940d1_ex99-3img03.jpg GRAPHIC 169475
10 GRAPHIC tm2012940d1_ex99-3img04.jpg GRAPHIC 131168
11 GRAPHIC tm2012940d1_ex99-3img05.jpg GRAPHIC 126421
12 GRAPHIC tm2012940d1_ex99-3img06.jpg GRAPHIC 90730
13 GRAPHIC tm2012940d1_ex99-3img07.jpg GRAPHIC 83203
14 GRAPHIC tm2012940d1_ex99-3img08.jpg GRAPHIC 75547
15 GRAPHIC tm2012940d1_ex99-3img09.jpg GRAPHIC 83321
16 GRAPHIC tm2012940d1_ex99-3img10.jpg GRAPHIC 117078
17 GRAPHIC tm2012940d1_ex99-3img11.jpg GRAPHIC 83438
18 GRAPHIC tm2012940d1_ex99-3img12.jpg GRAPHIC 91706
19 GRAPHIC tm2012940d1_ex99-3img13.jpg GRAPHIC 143395
20 GRAPHIC tm2012940d1_ex99-3img14.jpg GRAPHIC 74491
21 GRAPHIC tm2012940d1_ex99-3img15.jpg GRAPHIC 38902
22 GRAPHIC tm2012940d1_ex99-3img16.jpg GRAPHIC 76934
23 GRAPHIC tm2012940d1_ex99-3img17.jpg GRAPHIC 87949
  Complete submission text file 0001104659-20-034397.txt   3299260
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Filer) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36295 | Film No.: 20719323
SIC: 2834 Pharmaceutical Preparations